The class II phosphoinositide 3-kinase C2β is not essential for epidermal differentiation

被引:51
作者
Harada, K
Truong, AB
Cai, T
Khavari, PA
机构
[1] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA
[2] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA
关键词
D O I
10.1128/MCB.25.24.11122-11130.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphoinositide 3-kinases (PI3Ks) regulate an array of cellular processes and are comprised of three classes. Class I PI3Ks include the well-studied agonist-sensitive p110 isoforms; however, the functions of class II and III PI3Ks are less well characterized. Of the three class II PI3Ks, C2 alpha and C2 beta are widely expressed in many tissues, including the epidermis, while C2 gamma is confined to the liver. In contrast to the class I PI3K p110 alpha, which is expressed throughout the epidermis, C2 beta was found to be localized in suprabasal cells, suggesting a potential role for C2 beta in epidermal differentiation. Overexpressing C2 beta in epidermal cells in vitro induced differentiation markers. To study a role for C2 beta in tissue, we generated transgenic mice overexpressing C2 beta in both suprabasal and basal epidermal layers. These mice lacked epidermal abnormalities. Mice deficient in C2 beta were then generated by targeted gene deletion. C2 beta knockout mice were viable and fertile and displayed normal epidermal growth, differentiation, barrier function, and wound healing. To exclude compensation by C2 alpha, RNA interference was then used to knock down both C2 alpha and C2 beta in epidermal cells simultaneously. Induction of differentiation markers was unaffected in the absence of C2 alpha and C2 beta. These findings indicate that class II PI3Ks are not essential for epidermal differentiation.
引用
收藏
页码:11122 / 11130
页数:9
相关论文
共 33 条
[1]   Class I phosphoinositide 3-kinases [J].
Anderson, KE ;
Jackson, SP .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (07) :1028-1033
[2]   Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation [J].
Arcaro, A ;
Khanzada, UK ;
Vanhaesebroeck, B ;
Tetley, TD ;
Waterfield, MD ;
Seckl, MJ .
EMBO JOURNAL, 2002, 21 (19) :5097-5108
[3]   Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors [J].
Arcaro, A ;
Zvelebil, MJ ;
Wallasch, C ;
Ullrich, A ;
Waterfield, MD ;
Domin, J .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) :3817-3830
[4]   Human phosphoinositide 3-kinase C2β, the role of calcium and the C2 domain in enzyme activity [J].
Arcaro, A ;
Volinia, S ;
Zvelebil, MJ ;
Stein, R ;
Watton, SJ ;
Layton, MJ ;
Gout, I ;
Ahmadi, K ;
Downward, J ;
Waterfield, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :33082-33090
[5]   Topical treatment with inhibitors of the phosphatidylinositol 3′-kinase/akt and raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodericient mice [J].
Bedogni, B ;
O'Neill, MS ;
Welford, SM ;
Bouley, DM ;
Giaccia, AJ ;
Denko, NC ;
Powell, MB .
CANCER RESEARCH, 2004, 64 (07) :2552-2560
[6]   Growth factor regulation of the novel class II phosphoinositide 3-kinases [J].
Brown, RA ;
Shepherd, PR .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 :535-537
[7]   Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 [J].
Brunn, GJ ;
Williams, J ;
Sabers, C ;
Wiederrecht, G ;
Lawrence, JC ;
Abraham, RT .
EMBO JOURNAL, 1996, 15 (19) :5256-5267
[8]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[9]   Corrective gene transfer in the human skin disorder lamellar ichthyosis [J].
Choate, KA ;
Medalie, DA ;
Morgan, JR ;
Khavari, PA .
NATURE MEDICINE, 1996, 2 (11) :1263-1267
[10]   Hepatocyte growth factor activates phosphoinositide 3-kinase C2β in renal brush-border plasma membranes [J].
Crljen, V ;
Volinia, S ;
Banfic, H .
BIOCHEMICAL JOURNAL, 2002, 365 :791-799